Long‐term low level of ROS can promote the proliferation of breast cancer cells, increase survival and tumorigenicity, up‐regulate the level of VEGF, and induce angiogenesis (Abdullah, Mohammed, Rasedee, & Mirghani, 2015). This evidence concerns the gene VEGFA and breast cancer.